These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2561145)

  • 1. Comparison of the acute and chronic antihypertensive effect of two once-daily doses of spirapril by invasive twenty-four-hour ambulatory blood pressure monitoring.
    van den Meiracker AH; Man in 't Veld AJ; Ritsema van Eck HJ; Schalekamp MA
    J Hypertens Suppl; 1989 Dec; 7(6):S302-3. PubMed ID: 2561145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response?
    van den Meiracker AH; Man in 't Veld AJ; Admiraal PJ; Ritsema van Eck HJ; Boomsma F; Derkx FH; Schalekamp MA
    J Hypertens; 1992 Aug; 10(8):803-12. PubMed ID: 1325513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 24-hour ambulatory blood pressure monitoring and spirapril in mild to severe essential hypertension: a randomized dose comparison.
    Vreugdenhil G; van Montfrans GA; Jacobs MC; de Bruijn JH; Veerman DP; van Es PN; Mellein B; Guitard C; Thien T; de Leeuw PW
    Blood Press Suppl; 1994; 2():23-30. PubMed ID: 8061842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the efficacy and tolerability of a low-dose combination of isradipine and spirapril in the first-line treatment of mild to moderate essential hypertension.
    Pittrow DB; Antlsperger A; Welzel D; Wambach G; Schardt W; Weidinger G
    Cardiovasc Drugs Ther; 1997 Nov; 11(5):619-27. PubMed ID: 9493699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACE-inhibitor therapy with spirapril increases nocturnal hypotensive episodes in elderly hypertensive patients.
    Kantola I; Terént A; Kataja M; Breig-Asberg E
    J Hum Hypertens; 2001 Dec; 15(12):873-8. PubMed ID: 11773991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebo-controlled crossover comparison of spirapril at 3, 6, 12 and 24 mg once daily in mild to severe essential hypertension.
    Guitard C; Sassano P; Tzincoca C; Duchiez J; Safar ME
    Blood Press Suppl; 1994; 2():61-8. PubMed ID: 8061848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension.
    Whelton A; Dunne B; Glazer N; Kostis JB; Miller WE; Rector DJ; Tresznewsky ON
    J Hum Hypertens; 1992 Aug; 6(4):325-31. PubMed ID: 1331444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing.
    Pelttari LH; Hietanen EK; Salo TT; Kataja MJ; Kantola IM
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):272-9. PubMed ID: 9544866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and chronic effects of spirapril, alone or in combination with isradipine on kidney function and blood pressure in patients with reduced kidney function and hypertension.
    Shohat J; Wittenberg C; Erman A; Rosenfeld J; Boner G
    Scand J Urol Nephrol; 1999 Feb; 33(1):57-62. PubMed ID: 10100366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experience and comparison of antihypertensive effect of ace inhibitor spirapril and calcium antagonist amlodipinein standard and chronotherapeutic prescription mode].
    Ovchan HO; Khomenko VM; Andrushko II; Ostapchuk OI; Kyrychenko LM
    Wiad Lek; 2017; 70(4):721-724. PubMed ID: 29064793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration-time-dependent effects of spirapril on ambulatory blood pressure in uncomplicated essential hypertension.
    Hermida RC; Ayala DE; Fontao MJ; Mojón A; Alonso I; Fernández JR
    Chronobiol Int; 2010 May; 27(3):560-74. PubMed ID: 20524801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single daily administration of spirapril in the treatment of essential hypertension. A multicentre double-blind comparison of 1, 6, 12 and 24 mg of spirapril once daily.
    Hayduk K; Schardt F; Sierakowski B; Weidinger G; Welzel D
    Blood Press Suppl; 1994; 2():41-6. PubMed ID: 8061845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the acute and chronic antihypertensive effects of lisinopril and enalapril assessed by ambulatory blood pressure monitoring.
    Gourlay S; McNeil J; Forbes A; McGrath B
    Clin Exp Hypertens; 1993 Jan; 15(1):71-89. PubMed ID: 8385525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicentre multidose study of the efficacy and safety of spirapril in mild-to-moderate essential hypertension. UK Study Group of Spirapril in Hypertension.
    Fairhurst GJ
    Blood Press Suppl; 1994; 2():77-80. PubMed ID: 8061852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placebo-controlled comparison of spirapril at 6, 12 and 24 mg/day in mild to severe essential hypertension.
    Guitard C; Alvisi V; Maibach E; Franck J; Cocco G; Boxho G; Mellein B; Waite R
    Blood Press Suppl; 1994; 2():81-7. PubMed ID: 8061853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood pressure lowering by the ACE-inhibitor spirapril. "24-hour efficacy of real once daily application of spirapril (HERAS study)"].
    Düsing R; Müller U
    MMW Fortschr Med; 2003 Oct; 145 Suppl 3():77-80. PubMed ID: 15490771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spirapril. A preliminary review of its pharmacology and therapeutic efficacy in the treatment of hypertension.
    Noble S; Sorkin EM
    Drugs; 1995 May; 49(5):750-66. PubMed ID: 7601014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of spirapril in mild-to-moderate hypertension.
    Hayduk K; Kraul H
    J Cardiovasc Pharmacol; 1999 Aug; 34 Suppl 1():S19-23. PubMed ID: 10499560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
    White WB; Lacourciere Y; Davidai G
    Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients.
    Pechère-Bertschi A; Nussberger J; Decosterd L; Armagnac C; Sissmann J; Bouroudian M; Brunner HR; Burnier M
    J Hypertens; 1998 Mar; 16(3):385-93. PubMed ID: 9557932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.